The effect of 0.25% apraclonidine in preventing intraocular pressure elevation after Nd:YAG laser posterior capsulotomy

European Journal of Ophthalmology

Volumn 8, Issue 3, 1998, Pages 167-172

  Simsek, S ^a   Erturk H ^b   Demirok, A ^a   Cinal, A ^a   Yasar, T ^a   Karadenizli, C ^b  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

^b ULUDAG UNIVERSITY   (Turkey)

Author keywords

Apraclonidine; Nd YAG laser; Posterior capsulotomy; Timolol maleate

Indexed keywords

APRACLONIDINE; TIMOLOL MALEATE;

ADULT; AGED; ANXIETY; ARTICLE; BRONCHOSPASM; CAPSULOTOMY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EARLY DIAGNOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAOCULAR PRESSURE ABNORMALITY; MAJOR CLINICAL STUDY; MALE; NEODYMIUM LASER; PHACOEMULSIFICATION; PRIORITY JOURNAL; PUNCTATE KERATITIS;

EID: 0031715452     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067219800800309     Document Type: Article

References (28)

1. Mamalis N, Crandall AS, Linebarger E, Sheffield WK, Leidenix MJ. Effect of intraocular lens size on posterior capsule after phacoemulsification. J Cataract Refract Surg 1995; 1: 99-102.
2. Shepherd JR. Capsular opacification associated with silicone implants. J Cataract Refract Surg 1989; 4: 448-50.
3. Aron RD, Aron JJ, Griesmann M, Thyzel R. Use of the neodymium-YAG laser to open the posterior capsule after lens implant surgery. A preliminary report. J Am Intraocul Implant Soc 1980; 6: 352-5.
4. Flohr MJ, Robin AL, Kelley JS. Early complications following Q-switched neodymium-YAG laser posterior capsulotomy. Ophthalmology 1985; 92: 360-3.
5. Içagasioglu A, Kadioglu E, Küçümen B, Yilmaz ÖF. Laser posterior kapsülotomiden sonra yükselen intraoküler basincin tedavisi. T Oft Gaz 1991; 21: 366-9.
6. Channel MM, Beckmann H. Intraocular pressure changes after neodymium-YAG laser posterior capsulotomy. Arch Ophthalmol 1984; 102: 1024-6.
7. Richter CU, Arzeno G, Pappas HR, et al. Prevention of intraocular pressure elevation following neodymium-YAG laser posterior capsulotomy. Arch Ophthalmol 1985; 103: 912-5.
8. Grahagozloo NZ, Relf SJ, Brubaker RF, et al. Aqueous flow is reduced by the alpha adrenergic agonist, apraclonidine hydrochloride (ALO 2145). Ophthalmology 1988; 95: 1217-20.
9. Karadenizli C, Ertürk H, Yücel A. Nd-YAG laser kapsülotomide GIB artisinin önlenmesi. In: Dogan OK, Aydin RÇ, eds. XXVIII. U.T.Oft Kong. Bült, Antalya, Yeni Inan Matb, Tekirdag 1994; 1: 346-9.
10. Brown SV, Thomas JV, Belcher CD, Simmons RJ. Effect of pilocarpine in treatment of intraocular pressure elevation following neodymium-YAG laser posterior capsulotomy. Ophthalmology 1985; 92: 354-9.
11. Millichamp NJ, Dziezyc J, Olsen JV. Effect of flurbrofen on facility of aqueous outflow in the eyes of dogs. Am J Vet Res 1991; 52: 1448-51.
12. Grahagozloo NZ, Brubaker RF. Effect of apraclonidine in long-term timolol users. Ophthalmology 1991; 98: 1543-6.
13. Abrams DA, Robin AL, Pollack IP, De Faller JM, De Santis L. The safety and efficacy of topical 1% ALO 2145 (p-Aminoclonidine hydroclonidine) in normal volunteers. Arch Ophthalmol 1987; 105: 1205-7.
14. Boen-Tan TN, Stilma JS. Prevention of IOP rise following Nd-YAG laser capsulotomy with pre-operative timolol eye drops and 1 tablet acetazolamide 250 mg systematically. Doc Ophthalmol 1986; 64: 59-67.
15. Fourman S, Apisson J. Late-onset elevation in intraocular pressure after neodymium-YAG laser posterior capsulotomy. Arch Ophthalmol 1991; 109: 511-3.
16. Stark WJ, Worthen D, Holaday JT. Neodymium-YAG lasers: an FDA report. Ophthalmology 1985; 92: 209-12.
17. Terry AC, Stark WJ, Maumanee AE, Fagadau W. Nd-YAG laser for posterior capsulotomy. Am J Ophthalmol 1983; 96: 716-20.
18. Duy TP, Wollensak J, Becker U. Intraoculare druck-steigerung nach Nd-YAG laser kapsulotomie. Pathogenese und prophylaktische therapie. Klin Mbl Augenheilkd 1987; 191: 270-4.
19. Abrams DA, Robin AL, Crandall AS, et al. A limited comparison of apraclonidine dose-response in subjects with normal or increased intraocular pressure. Am J Ophthalmol 1989; 108: 230-7.
20. Makoto A, Kyoshi I. Effect of apraclonidine on intraocular pressure and blood-aqueous barrier permeability after phacoemulsification and intraocular lens implantation. Am J Ophthalmol 1993; 116: 67-71.
21. Jampel HD, Robin AL, Quigley HA, et al. Apraclonidine. A one-week dose-response study. Arch Ophthalmol 1988; 106: 1069.
22. Migliori ME, Beckman H, Channel MM. Intraocular pressure changes after neodymium-YAG laser capsulotomy in eyes pretreated with timolol. Arch Ophthalmol 1987; 105: 473-5.
23. Pollack IP, Brown RH, Crandal AS, Robin AL, et al. Prevention of the rise in intraocular pressure following neodymium-YAG posterior capsulotomy using topical 1% apraclonidine. Arch Ophthalmol 1988; 106: 754-7.
24. Özdamar MA, Akar S, Cicik E. et al. Nd-YAG laser arka kapsülotomi sonrasi göz içi basinci yükselmesini önlemede topikal %1 apraklonidin kullanimi. XXV. U.T.Oft. Kong Bült Istanbul 1991; 3: 88-90.
25. Frishman WH, Fuksbrumer MS, Tannenbaum M, et al. Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension. J Clin Pharmacol 1994; 34: 795-803.
26. Lehto I. Side effects of topical treatment in pigmentary . glaucoma. Acta Ophthalmol 1992; 2: 225-7.
27. Robin AL. Short-term effects of unilateral 1% apraclonidine therapy. Arch Ophthalmol 1988; 106: 912-5.
28. King MH, Richard DW. Near syncope and chest tightness after administration of arpaclonidine before argon laser iridotomy. Am J Ophthalmol 1990; 110: 308-9.